Cash carries dangerous, sometimes life-threatening bacteria as it passes through countless hands and contaminated ...
Modern medicine has dramatically improved quality of life. Advanced surgical procedures, implantable devices and targeted ...
A Missouri couple has been charged with child endangerment after they allegedly allowed a child suffer with a serious staph ...
A recent study found permanent pacemaker infection (PPMI) in 2.09% patients, with infections more prevalent in devices ...
Detailed price information for Armata Pharmaceuticals Inc (ARMP-A) from The Globe and Mail including charting and trades.
FDA agreed that data from the Phase 2a diSArm study support advancement of AP-SA02 to a Phase 3study First bacteriophage company to advance a clinical candidate to ...
Armata Pharmaceuticals, Inc. ("Armata" or the "Company"), a late clinical-stage biotechnology company focused on the development of high-purity, pathogen-specific bacteriophage therapeutics for the ...
6d
Ciprofloxacin, a common antibiotics, becomes ineffective in majority of cases, finds SMS Hosp study
Bacteria learned to survive by developing their own defence mechanism against antibiotic use, finds a 2025 study report by ...
Select gut bacteria protect mice against post-influenza virus secondary bacterial pneumonia, according to a study published ...
Picking your nose and then sticking those boogers to the wall may be convenient, but could come with unexpected health ...
Experts warn that antibiotic misuse is fueling drug-resistant infections like gonorrhoea and staph, making them harder to ...
Innocan Pharma Corp., of Herzliya, Israel, plans to list on the NYSE American exchange on or around Jan. 7, 2026, and is also conducting a concurrent offering of securities subject to market ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback